\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ was\\ not\\ given\\.\ \(0\)\
\-\ fetal\\ hr\\ on\\ ultrasound\\ exam\\:\\ 134\ \(0\)\
\-\ most\\ recent\\ laboratory\\ values\\ were\\:\ \(0\)\
\-\ wbc\\:\\ 8\\.5\ \(0\)\
\-\ hgb\\:\\ 12\\.6\ \(0\)\
\-\ hct\\:\\ 36\\.7\ \(0\)\
\-\ gc\\/chlamydia\\:\\ neg\ \(0\)\
\-\ rpr\\:\\ non\\-reactive\ \(0\)\
\-\ negative\\ screen\\ for\\ neural\\ tube\\ defects\\,\\ down\\ syndrome\\,\\ and\\ trisomy\\ 18\ \(0\)\
\-\ normal\\ amniotic\\ fluid\\ volume\\ on\\ ultrasound\ \(0\)\
\-\ chromosomal\\ panel\\ and\\ afp\\:\\ pending\ \(0\)\
\-\ close\\ observation\\.\\ \\ amniotic\\ fluid\\ levels\\ will\\ likely\\ be\\ closely\\ monitored\\.\\ \\ primary\\ concern\\ is\\ nonimmune\\ hydrops\\.\\ \\ doppler\\ ultrasound\\ can\\ evaluate\\ the\\ vascularity\\ of\\ the\\ mass\\ to\\ further\\ evaluate\\ risk\\ of\\ high\\ output\\ chf\\.\\ \\ fetal\\ surgery\\ has\\ been\\ done\\ in\\ cases\\ of\\ hydrops\\,\\ but\\ is\\ still\\ largely\\ experimental\\.\\ \\ if\\ fetus\\ is\\ delivered\\ at\\ term\\,\\ surgical\\ resection\\ of\\ teratoma\\ is\\ likely\\ course\\.\\ \\ close\\ follow\\-up\\ even\\ after\\ surgical\\ removal\\ is\\ necessary\\.\ \(0\)\
\-\ large\\ sacral\\ mass\\ with\\ mixture\\ of\\ cystic\\ and\\ solid\\ components\\ with\\ no\\ apparent\\ involvement\\ of\\ the\\ spine\\.\ \(0\)\
\-\ sacrococcygeal\\ teratoma\ \(6\)\
\-\ \\â\\€\\¢\\ sacrococcygeal\\ teratoma\ \(1\)\
\-\ \\â\\€\\¢\\ meningocele\\,\\ myelomeningocele\ \(1\)\
\-\ \\â\\€\\¢\\ epidermoid\\ or\\ dermoid\\ cyst\ \(1\)\
\-\ \\â\\€\\¢\\ rhabdomyosarcoma\ \(2\)\
\-\ the\\ patient\\ is\\ a\\ 20\\ year\\-old\\ g1p0\\ woman\\ with\\ no\\ significant\\ past\\ medical\\ history\\ noted\\ to\\ have\\ an\\ abnormality\\ on\\ routine\\ ultrasound\\ at\\ 20\\ weeks\\ gestational\\ age\\.\\ \\ the\\ patient\\ now\\ presents\\ for\\ follow\\-up\\ fetal\\ mri\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fetal\\:\\ 0\\.23571071112741582\ \(0\)\
\-\ sacrococcygeal\\:\\ 0\\.2296377158132218\ \(0\)\
\-\ hydrops\\:\\ 0\\.22614151110364805\ \(0\)\
\-\ teratoma\\:\\ 0\\.21963653857973908\ \(0\)\
\-\ ultrasound\\:\\ 0\\.2088857236761696\ \(0\)\
\-\ amniotic\\:\\ 0\\.20243906233766462\ \(0\)\
\-\ close\\:\\ 0\\.15321716226809867\ \(0\)\
\-\ is\\:\\ 0\\.13911248344296348\ \(0\)\
\-\ evaluate\\:\\ 0\\.13166886071569514\ \(0\)\
\-\ nonimmune\\:\\ 0\\.1251063514475794\ \(0\)\
\-\ experimental\\:\\ 0\\.1148188579066109\ \(0\)\
\-\ 20\\:\\ 0\\.10923805487934883\ \(0\)\
\-\ 134\\:\\ 0\\.10761308883039658\ \(0\)\
\-\ chromosomal\\:\\ 0\\.10761308883039658\ \(0\)\
\-\ myelomeningocele\\:\\ 0\\.10761308883039658\ \(0\)\
\-\ g1p0\\:\\ 0\\.10548922676192315\ \(0\)\
\-\ rpr\\:\\ 0\\.10453136436564237\ \(0\)\
\-\ trisomy\\:\\ 0\\.10453136436564237\ \(0\)\
\-\ meningocele\\:\\ 0\\.10453136436564237\ \(0\)\
\-\ likely\\:\\ 0\\.10118449175298029\ \(0\)\
\-\ mixture\\:\\ 0\\.10049540141279645\ \(0\)\
\-\ output\\:\\ 0\\.09980496455639445\ \(0\)\
\-\ of\\:\\ 0\\.09940851519619084\ \(0\)\
\-\ fluid\\:\\ 0\\.09776458009910409\ \(0\)\
\-\ largely\\:\\ 0\\.09676546406297781\ \(0\)\
\-\ delivered\\:\\ 0\\.09520173322095463\ \(0\)\
\-\ chf\\:\\ 0\\.09291387262289556\ \(0\)\
\-\ neg\\:\\ 0\\.09130779734155035\ \(0\)\
\-\ closely\\:\\ 0\\.09093203762786378\ \(0\)\
\-\ monitored\\:\\ 0\\.09093203762786378\ \(0\)\
\-\ sacral\\:\\ 0\\.0902079078718279\ \(0\)\
\-\ afp\\:\\ 0\\.08918393527307693\ \(0\)\
\-\ panel\\:\\ 0\\.08885773058344047\ \(0\)\
\-\ fetus\\:\\ 0\\.08853854159514697\ \(0\)\
\-\ screen\\:\\ 0\\.08732629946235851\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.08567552018361686\ \(0\)\
\-\ exam\\:\\ 0\\.08523833779569132\ \(0\)\
\-\ vascularity\\:\\ 0\\.0846689164761574\ \(0\)\
\-\ the\\:\\ 0\\.08446623000641218\ \(0\)\
\-\ surgical\\:\\ 0\\.08229751982877208\ \(0\)\
\-\ hgb\\:\\ 0\\.08220827492891845\ \(0\)\
\-\ gestational\\:\\ 0\\.08220827492891845\ \(0\)\
\-\ hct\\:\\ 0\\.08027806334563642\ \(0\)\
\-\ observation\\:\\ 0\\.0793995989311475\ \(0\)\
\-\ neural\\:\\ 0\\.07840978449687516\ \(0\)\
\-\ values\\:\\ 0\\.07809399139371598\ \(0\)\
\-\ concern\\:\\ 0\\.07763255373280033\ \(0\)\
\-\ components\\:\\ 0\\.07689400754443645\ \(0\)\
\-\ on\\:\\ 0\\.0767086279156214\ \(0\)\
\-\ doppler\\:\\ 0\\.07578382918978567\ \(0\)\
\-\ still\\:\\ 0\\.07500250585270414\ \(0\)\
\-\ volume\\:\\ 0\\.07438142293518886\ \(0\)\
\-\ epidermoid\\:\\ 0\\.07355338342508724\ \(0\)\
\-\ defects\\:\\ 0\\.07298899162277461\ \(0\)\
\-\ hr\\:\\ 0\\.07276911032829915\ \(0\)\
\-\ dermoid\\:\\ 0\\.07151413359669483\ \(0\)\
\-\ even\\:\\ 0\\.07121629652679375\ \(0\)\
\-\ necessary\\:\\ 0\\.07082825570697428\ \(0\)\
\-\ apparent\\:\\ 0\\.07082825570697428\ \(0\)\
\-\ pending\\:\\ 0\\.06963292078989085\ \(0\)\
\-\ down\\:\\ 0\\.06877477914444716\ \(0\)\
\-\ tube\\:\\ 0\\.06765108579485907\ \(0\)\
\-\ done\\:\\ 0\\.0673450601918318\ \(0\)\
\-\ levels\\:\\ 0\\.06711961207087244\ \(0\)\
\-\ term\\:\\ 0\\.06639193124030958\ \(0\)\
\-\ routine\\:\\ 0\\.06556334125208485\ \(0\)\
\-\ solid\\:\\ 0\\.06490652098064294\ \(0\)\
\-\ removal\\:\\ 0\\.06471501231173561\ \(0\)\
\-\ mass\\:\\ 0\\.06467766633102205\ \(0\)\
\-\ 18\\:\\ 0\\.06415488108528537\ \(0\)\
\-\ at\\:\\ 0\\.06395623219150726\ \(0\)\
\-\ course\\:\\ 0\\.06253628246944352\ \(0\)\
\-\ abnormality\\:\\ 0\\.06158184337289299\ \(0\)\
\-\ laboratory\\:\\ 0\\.06147948630571493\ \(0\)\
\-\ involvement\\:\\ 0\\.06127686587663602\ \(0\)\
\-\ risk\\:\\ 0\\.06049296271755692\ \(0\)\
\-\ wbc\\:\\ 0\\.05983944827290238\ \(0\)\
\-\ given\\:\\ 0\\.05823922886692008\ \(0\)\
\-\ now\\:\\ 0\\.05811673808156282\ \(0\)\
\-\ recent\\:\\ 0\\.057324992190742066\ \(0\)\
\-\ cases\\:\\ 0\\.05694441452021567\ \(0\)\
\-\ spine\\:\\ 0\\.05592795861745454\ \(0\)\
\-\ further\\:\\ 0\\.05514213765437577\ \(0\)\
\-\ past\\:\\ 0\\.055108897515252435\ \(0\)\
\-\ patient\\:\\ 0\\.05507295327271332\ \(0\)\
\-\ no\\:\\ 0\\.05506259437125434\ \(0\)\
\-\ will\\:\\ 0\\.054491080820442836\ \(0\)\
\-\ resection\\:\\ 0\\.054269794481779966\ \(0\)\
\-\ medical\\:\\ 0\\.05380643585325181\ \(0\)\
\-\ age\\:\\ 0\\.05315198564264288\ \(0\)\
\-\ and\\:\\ 0\\.052483436936123604\ \(0\)\
\-\ negative\\:\\ 0\\.05241400454083754\ \(0\)\
\-\ primary\\:\\ 0\\.05205833349846495\ \(0\)\
\-\ for\\:\\ 0\\.05132113694757837\ \(0\)\
\-\ syndrome\\:\\ 0\\.05103976870298558\ \(0\)\
\-\ cystic\\:\\ 0\\.05098937233566749\ \(0\)\
\-\ weeks\\:\\ 0\\.050739925860270464\ \(0\)\
\-\ with\\:\\ 0\\.04973395588016641\ \(0\)\
\-\ been\\:\\ 0\\.049325359247832594\ \(0\)\
\-\ if\\:\\ 0\\.04919104415997092\ \(0\)\
\-\ significant\\:\\ 0\\.048882290049552045\ \(0\)\
\-\ cyst\\:\\ 0\\.04883870201259936\ \(0\)\
\-\ high\\:\\ 0\\.04811664497717501\ \(0\)\
\-\ physical\\:\\ 0\\.04590597691435523\ \(0\)\
\-\ surgery\\:\\ 0\\.045518166548806055\ \(0\)\
\-\ noted\\:\\ 0\\.04488795886570006\ \(0\)\
\-\ can\\:\\ 0\\.04442822294369755\ \(0\)\
\-\ woman\\:\\ 0\\.044092531698343575\ \(0\)\
\-\ most\\:\\ 0\\.04406095356746337\ \(0\)\
\-\ were\\:\\ 0\\.043641097042303886\ \(0\)\
\-\ mri\\:\\ 0\\.043458239913084694\ \(0\)\
\-\ large\\:\\ 0\\.04242013907346223\ \(0\)\
\-\ to\\:\\ 0\\.04233094128398405\ \(0\)\
\-\ have\\:\\ 0\\.04229358648933188\ \(0\)\
\-\ but\\:\\ 0\\.04186576217361112\ \(0\)\
\-\ after\\:\\ 0\\.04107118979400439\ \(0\)\
\-\ presents\\:\\ 0\\.040727055587699464\ \(0\)\
\-\ has\\:\\ 0\\.038671384965605224\ \(0\)\
\-\ normal\\:\\ 0\\.03456715057243871\ \(0\)\
\-\ be\\:\\ 0\\.03434421100944222\ \(0\)\
\-\ not\\:\\ 0\\.03342275995223546\ \(0\)\
\-\ an\\:\\ 0\\.03237467408105643\ \(0\)\
\-\ history\\:\\ 0\\.03234599442785249\ \(0\)\
\-\ was\\:\\ 0\\.029505736099420154\ \(0\)\
\-\ or\\:\\ 0\\.029452592838648782\ \(0\)\
\-\ in\\:\\ 0\\.021061294239327333\ \(0\)\
